Download PDF
Horm Metab Res 1984; 16(8): 435-438
DOI: 10.1055/s-2007-1014810
Originals

© Georg Thieme Verlag, Stuttgart · New York

The “So-Called” Somatomedin B and Growth Hormone Measured by Radioimmunoassay in Normal and Cirrhotic Individuals

F. H. D'Abronzo1 , O. Z. Higa1 , A. A. Laudana2 , S. S. Lima3
  • 1Instituto de Pesquisas Energéticas e Nucleares (IPEN), São Paulo, Brasil
  • 2Hospital Beneficiência Portuguêse, São Paulo, Brasil
  • 3Hospital das Clínicas, São Paulo, Brasil
Further Information

Publication History

1983

1983

Publication Date:
14 March 2008 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

Serum somatomedin B (SmB) levels in cirrhotic individuals, 3,3 ± 1.5 mg/l, were strikingly lower (P < 0.001) than in normal subjects, 9.0 ± 1.7 mg/l. SmB levels were clearly related to the levels of α2-globulins in the cirrhotics (r = + 0.8, P < 0.002). Serum SmB and growth hormone correlated negatively in a group of normal and cirrhotic individuals (r = -0.67, P < 0.001). Direct measurements of serum SmB failed to reveal differences between hepatic, renal and peripheral veins.

These findings suggest that: 1) SmB is produced by liver and/or normal liver function plays an important role in maintaining normal serum SmB levels; 2) SmB carrier proteins are reduced in the cirrhotics and 3) SmB is part of a negative feed-back system involving growth hormone.

Key-Words:

Somatomedin - Growth Hormone - Carrier Proteins - Feed-Back - Liver Cirrhosis